Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-08 4:01 pm Purchase | 2024-05-01 | 13D | Fresh Tracks Therapeutics, Inc. FRTX | Exploration Capital LLC | 1,273,024 21.300% | 376,024 (+41.92%) | Filing History |
| 2024-01-17 8:37 pm Purchase | 2024-01-17 | 13G | Fresh Tracks Therapeutics, Inc. FRTX | Exploration Capital LLC | 897,000 15.000% | 897,000 (New Position) | Filing History |
| 2023-11-27 6:01 pm Purchase | 2023-11-17 | 13G | Fresh Tracks Therapeutics, Inc. FRTX | Exploration Capital Fund LP | 597,000 9.990% | 597,000 (New Position) | Filing History |
| 2023-02-13 5:24 pm Sale | 2022-12-31 | 13G | Brickell Biotech, Inc. BBI | Ionic Ventures, LLC | 0 0.000% | -135,444 (Position Closed) | Filing History |
| 2022-02-03 3:37 pm Sale | 2021-12-31 | 13G | Brickell Biotech, Inc. BBI | Ionic Ventures, LLC | 135,444 5.300% | -26,468 (-16.35%) | Filing History |
| 2021-11-03 12:45 pm Purchase | 2021-10-28 | 13G | Brickell Biotech, Inc. BBI | Ionic Ventures, LLC | 161,913 6.330% | 57,289 (+54.76%) | Filing History |
| 2021-07-22 08:59 am Purchase | 2021-07-22 | 13G | Brickell Biotech, Inc. BBI | Ionic Ventures, LLC | 104,623 5.700% | 104,623 (New Position) | Filing History |
| 2021-02-16 09:54 am Purchase | 2020-12-31 | 13G | Brickell Biotech, Inc. BBI | CVI Investments, Inc. | 62,459 4.900% | 19,569 (+45.63%) | Filing History |
| 2021-02-11 4:30 pm Sale | 2020-12-31 | 13G | Brickell Biotech, Inc. BBI | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -14,757 (Position Closed) | Filing History |
| 2020-09-24 3:47 pm Purchase | 2020-09-14 | 13D | Brickell Biotech, Inc. BBI | Palisade Concentrated Equity Partnership II LP | 23,853 3.860% | 1,336 (+5.94%) | Filing History |
| 2020-06-26 4:39 pm Purchase | 2020-06-18 | 13G | Brickell Biotech, Inc. BBI | Armistice Capital, LLC | 29,583 4.990% | 29,583 (New Position) | Filing History |
| 2020-06-26 10:50 am Purchase | 2020-06-17 | 13G | Brickell Biotech, Inc. BBI | CVI Investments, Inc. | 42,890 7.900% | 42,890 (New Position) | Filing History |
| 2020-02-27 1:48 pm Purchase | 2020-02-20 | 13G | Brickell Biotech, Inc. BBI | Lincoln Park Capital Fund LLC | 21,461 9.990% | 21,461 (New Position) | Filing History |
| 2020-02-14 4:00 pm Unchanged | 2019-12-31 | 13G | Brickell Biotech, Inc. BBI | Sio Capital Management, LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2020-02-14 2:56 pm Purchase | 2019-12-31 | 13G | Brickell Biotech, Inc. BBI | BIOTECHNOLOGY VALUE FUND L P | 14,757 8.300% | 14,757 (New Position) | Filing History |
| 2020-02-14 10:49 am Unchanged | 2019-12-31 | 13G | Brickell Biotech, Inc. BBI | Armistice Capital, LLC | 0 0.000% | 0 (Unchanged) | Filing History |